Scott Trevino Promoted to Senior VP Product Management and Solutions at TRIMEDX

Scott Trevino has been promoted to senior vice president of product management and solutions at TRIMEDX, effective immediately.

In his new role, Scott Trevino will partner across the organization to develop, drive and execute the product strategy for TRIMEDX’s technology and analytics portfolio. He will serve as a member of the TRIMEDX executive leadership team reporting to Chief Marketing Officer LeAnne Hester.

Trevino and his team will manage the TRIMEDX portfolio to align with business strategy and outcomes, product innovation and development prioritization. This portfolio combines technology-enabled, best-in-class clinical engineering and cybersecurity with next-generation clinical asset management to transform a health system’s medical devices into a strategic lever for improving overall performance.

“We have been fortunate to have Scott as an integral member of our TRIMEDX team to drive a number of our key initiatives over the last two years,” says LeAnne Hester, chief marketing officer. “His experience in product management, regulatory, risk management and leadership will continue to advance our commitment to develop solutions that enable our clients to reduce cost and their overall risk.”

Trevino joined TRIMEDX in 2018 as vice president of quality assurance, regulatory and technology and has helped contribute to and drive key initiatives around cybersecurity, product development and recalls, as well as to establish the TRIMEDX brand and influence in the industry through his work establishing relationships with regulatory agencies and industry organizations such as the Association for the Advancement of Medical Instrumentation and with the Alliance for Quality Medical Device Servicing.

“I’m looking forward to becoming part of an extremely talented team with a clear vision for the future and a fantastic leader,” says Trevino. “I have a deep passion for our clients and the patients they serve. Together, we have the privilege to continue helping provide meaningful solutions for the providers, the clinicians and their patients.”

Prior to joining TRIMEDX, Trevino spent over 20 years at GE Healthcare holding multiple leadership positions in product management, service, technology/engineering, operations and quality. He has led successful transformative change across organizations by leveraging his unique experience, expertise and analytical approach. He is Six Sigma Lean Black Belt-certified with a history of success in executing complex global strategies and has a passion for developing, motivating and leading teams.

Trevino earned an MBA from The University of Chicago Booth School of Business, as well as a Master of Science in Computing, Bachelor of Science in Computer Science and Bachelor of Arts in Psychology from Marquette University.

SourceTRIMEDX

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”
Exit mobile version